In veterans with type 2 diabetes, treatment with GLP-1 receptor agonists was associated with a reduced risk for various substance use disorders compared with sodium-glucose cotransporter-2, or SGLT-2, ...

Originally designed for diabetes and obesity, GLP-1-based drugs may also blunt the brain's reward signals that drive alcohol, tobacco and drug cravings.

A study in The BMJ found GLP-1 drugs used for diabetes and obesity may also curb addiction by reducing cravings. Researchers ...

Public health advocates from the Finger Lakes region recently met with state lawmakers to discuss tobacco use trends, ...

A growing body of research has looked at GLP-1 drugs for alcohol use disorder. A new study shows the medications could have a ...

Katy Perry shared with her fans that she hasn’t used nicotine in a few months. The "Teenage Dream" singer had previously ...

Residency-trained clinical pharmacists delivered tobacco use disorder treatment within HIV clinics over 10 visits across 24 weeks, supporting feasibility of embedding cessation services in routine HIV ...

My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...